AYTU BIOPHARMA, INC

AYTU BIOPHARMA, INC (ticker: AYTU) is an NASDAQ-listed pharmaceutical preparations company. DredgeCap's structured extraction of AYTU's SEC filings surfaces 5 active risk signals, including 4 late-filing signals, and 1 auditor-change signal. AYTU reported $41.46M in revenue and -$14.24M for the period ending 2026-03-31, with operating cash flow of -$1.13M. Cash and equivalents stood at $26.71M (up 47% year-over-year). Total assets of $111.69M exceed total liabilities of $100.72M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.